TT
Telemachus Therapeutics, Inc.
SEC filingPharmaceuticals · Pittsburgh, PA
Amount raised$125Ksold at filing
Total offering$1.5M$1.4M still open
Investors in the raise1count reported to the SEC
FiledSep 2, 2026first sale Aug 20, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Gregory HebrankExecutive Officer, Director, Promoter
Michael BozikExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.